Brazil

ler em Portugues

We are engaged in the sales and distribution of medicines in the healthcare system of Brazil. Our operations span two divisions, retail and hospitals. The retail division caters to retail customers while the hospital division focusses on public hospitals, public agencies and private institutions. We have one of the most comprehensive product portfolios in the country covering various therapeutic indications. Our office in Barueri coordinates marketing and customer service operations for Brazil. Our Quality assurance operations are headquartered in Goiânia, Goiás.

PHARMACOVIGILANCE
Adverse drug reactions constitute an unwanted or unintended response as a result of its use. If you have any problem with your medication or any adverse reactions, please contact our Customer Service (SAC), using the telephone numbers provided on this page, or by email at [email protected].

WARNING MESSAGE TO CONSUMERS

Ranbaxy Pharmaceutical Ltd., aiming to ensure its commitment to patients’ health, safety, and integrity, hereby announces the voluntary recall of batch DFF4088A of the medication Amoxicillin + Potassium Clavulanate 500 mg + 125 mg coated tablets, after identifying degradation of the potassium clavulanate. The analyses carried out found swollen blisters, changes in the color of the tablets, and analytical results out of specification for content, dissolution, and uniformity of the clavulanate component. Although the observed occurrence is of low incidence, the company remains committed to the highest standards of quality, safety, and regulatory compliance and, for this reason, has decided to carry out the voluntary recall of the product available on the market. ASSOCIATED RISKS The identified quality issue can reduce the effectiveness of the medication in treating certain bacterial infections. This means the treatment may not produce the expected result.

CONSUMER GUIDANCE
If you are being treated with this medication, stop using units from the affected batch and promptly seek medical advice to assess the need for replacement, in order to avoid improper interruption of infection treatment.

RETURN PROCEDURE
Consumers, distributors, hospitals, clinics, pharmacies, and other establishments that have units from batch DFF4088A should contact the channels below for instructions on returning and collecting the product.
Phone: 0800 704 7222
E-mail: [email protected]